serw-MX  [xml]  
 


    
 DeCS Categories

D06 Hormones, Hormone Substitutes, and Hormone Antagonists .
D06.347 Hormone Antagonists .
D06.347.710 Prostaglandin Antagonists .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.519 Molecular Mechanisms of Pharmacological Action .
D27.505.519.389 Enzyme Inhibitors .
D27.505.519.389.174 Calcineurin Inhibitors .
D27.505.519.389.675 Nucleic Acid Synthesis Inhibitors .
D27.505.519.389.745 Protease Inhibitors .
D27.505.519.389.745.610 Matrix Metalloproteinase Inhibitors .
D27.505.519.389.745.705 Proteasome Inhibitors .
D27.505.519.389.892 Topoisomerase Inhibitors .
D27.505.519.389.892.500 Topoisomerase I Inhibitors .
D27.505.519.625 Neurotransmitter Agents .
D27.505.519.625.085 Cannabinoid Receptor Modulators .
D27.505.519.625.085.750 Cannabinoid Receptor Antagonists .
D27.505.519.625.487 Neurokinin-1 Receptor Antagonists .
D27.505.696 Physiological Effects of Drugs .
D27.505.696.399 Hormones, Hormone Substitutes, and Hormone Antagonists .
D27.505.696.399.450 Hormone Antagonists .
D27.505.696.399.450.710 Prostaglandin Antagonists .
D27.505.696.399.472 Hormones .
D27.505.696.399.472.188 Cannabinoid Receptor Modulators .
D27.505.696.399.472.188.750 Cannabinoid Receptor Antagonists .
D27.505.696.577 Neurotransmitter Agents .
D27.505.696.577.487 Neurokinin-1 Receptor Antagonists .
D27.505.954 Therapeutic Uses .
D27.505.954.248 Antineoplastic Agents .
D27.505.954.248.794 Topoisomerase Inhibitors .
D27.505.954.248.794.500 Topoisomerase I Inhibitors .
D27.888 Toxic Actions .
D27.888.569 Noxae .
D27.888.569.199 Cytostatic Agents .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Proteasome Inhibitors .
Proteasome Endopeptidase Complex Inhibitors .
Proteasome Inhibitor .
Inhibitor, Proteasome .
Inhibitors, Proteasome .
Compounds that inhibit the function or proteolytic action of the PROTEASOME. .
1.00
 
Prostaglandin Antagonists .
Antagonists, Prostaglandin .
Inhibitors, Prostaglandin .
Prostaglandin Antagonist .
Prostaglandin Inhibitor .
Antagonist, Prostaglandin .
Inhibitor, Prostaglandin .
Prostaglandin Inhibitors .
Compounds that inhibit the action of prostaglandins. .
0.64
 
Cytostatic Agents .
Cytostatic Drugs .
Cytostatics .
Compounds that inhibit or prevent the proliferation of CELLS. .
0.53
 
Nucleic Acid Synthesis Inhibitors .
DNA Polymerase Inhibitors .
Inhibitors, DNA Synthesis .
Inhibitors, Nucleic Acid Synthesis .
Inhibitors, RNA Synthesis .
Inhibitors, DNA Polymerase .
Polymerase Inhibitors, DNA .
Synthesis Inhibitors, DNA .
Synthesis Inhibitors, RNA .
DNA Synthesis Inhibitors .
RNA Synthesis Inhibitors .
Compounds that inhibit cell production of DNA or RNA. .
0.50
 
Calcineurin Inhibitors .
Calcineurin Antagonists .
Calcineurin Blockers .
Protein Phosphatase 3 Inhibitors .
Protein Phosphatase-2B Inhibitors .
Protein Phosphatase 2B Inhibitors .
Compounds that inhibit or block the PHOSPHATASE activity of CALCINEURIN. .
0.50
 
Topoisomerase Inhibitors .
DNA Topoisomerase Inhibitors .
Inhibitors, DNA Topoisomerase .
Inhibitors, Topoisomerase .
Topoisomerase Inhibitors, DNA .
Compounds that inhibit the activity of DNA TOPOISOMERASES. .
0.49
 
Cannabinoid Receptor Antagonists .
Cannabinoid Antagonists .
Cannabinoid Blockers .
Cannabinoid Receptor Blockers .
Antagonists, Cannabinoid .
Antagonists, Cannabinoid Receptor .
Blockers, Cannabinoid .
Blockers, Cannabinoid Receptor .
Receptor Antagonists, Cannabinoid .
Receptor Blockers, Cannabinoid .
Compounds that inhibit or block the activity of CANNABINOID RECEPTORS. .
0.49
 
Matrix Metalloproteinase Inhibitors .
Collagenase Inhibitors .
Gelatinase Inhibitors .
MMP Inhibitors .
Stromelysin Inhibitors .
Inhibitors, Collagenase .
Inhibitors, Gelatinase .
Inhibitors, MMP .
Inhibitors, Matrix Metalloproteinase .
Inhibitors, Stromelysin .
Metalloproteinase Inhibitors, Matrix .
Compounds that inhibit the enzyme activity or activation of MATRIX METALLOPROTEINASES. .
0.49
 
Topoisomerase I Inhibitors .
DNA Topoisomerase I Inhibitors .
DNA Type 1 Topoisomerase Inhibitors .
Inhibitors, Topoisomerase 1 .
Inhibitors, Topoisomerase I .
Topoisomerase 1 Inhibitors .
Compounds that inhibit the activity of DNA TOPOISOMERASE I. .
0.48
 
Neurokinin-1 Receptor Antagonists .
Neurokinin-1 Receptor Blockers .
Neuroleukin-1 Receptor Blockers .
Substance P Receptor Antagonists .
Substance P Receptor Blockers .
Tachykinin Receptor 1 Antagonists .
Tachykinin Receptor 1 Blockers .
Antagonists, Neurokinin-1 Receptor .
Blockers, Neurokinin-1 Receptor .
Blockers, Neuroleukin-1 Receptor .
Neurokinin 1 Receptor Antagonists .
Neurokinin 1 Receptor Blockers .
Neuroleukin 1 Receptor Blockers .
Receptor Antagonists, Neurokinin-1 .
Receptor Blockers, Neurokinin-1 .
Receptor Blockers, Neuroleukin-1 .
Compounds that inhibit or block the activity of NEUROKININ-1 RECEPTORS. .
0.47